Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therapix Biosciences Ltd ADR TRPX


Primary Symbol: TRPXY

Healthcare Biotechnology
Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Therapix Biosciences Ltd ADR > More News
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Post by StuinSeaon Mar 28, 2019 9:12am
99 Views
Post# 29547022

More News

More Newshttps://seekingalpha.com/news/3446463-therapix-bio-18-percent-pricing-registered-direct-offering?dr=1#email_link

Therapix Bio down 18% on pricing registered direct offering

|About: Therapix Biosciences Ltd. (TRPX)|By:, SA News Editor

Therapix Biosciences (NASDAQ:TRPX) has entered into definitive agreements with several institutional investors providing for the issuance of an aggregate of 642,853 ADS at a price of $3.50/ADS in a registered direct offering.

Additionally, in a concurrent private placement, the Company will issue warrants to purchase up to 482,139 ADSs. The warrants will have a term of 3 years, with an exercise price of $3.50/ADS.

Expected gross proceeds are ~$2.25M. Net proceeds will be used for general corporate, product development purposes and the repayment of a portion of outstanding debt.

Closing date is April 1.

Shares are down 18% premarket.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities